OncLive® On Air

Active· last episode 24 days ago

Rate this show

~15 min episodes

Episodes(50)

1
S8 Ep34: Mercado and Kovacs Emphasize the Importance of Multidisciplinary Lung Cancer Screening and Management
26 May27m
2
S8 Ep33: Kishan Discusses GI Toxicity Reduction With MRI-Guided SBRT in Prostate Cancer
26 May17m
3
S8 Ep19: FDA Approval Insights: Tucatinib and Trastuzumab in HER2+ mCRC
26 May10m
4
S8 Ep6: FDA Approval Insights: Tremelimumab Plus Durvalumab and Chemotherapy in NSCLC
26 May13m
5
S8 Ep5: Acuna Discusses US Liver Cancer Incidence in Individuals of Mexican Descent
26 May16m
6
S8 Ep36: FDA Approval Insights: Dostarlimab in dMMR Advanced Endometrial Cancer
26 May13m
7
S8 Ep35: Gynecologic Cancer Experts Review 2023 SGO Research and Treatment Updates
26 May22m
8
S8 Ep32: FDA Approval Insights: Elacestrant in ER+/HER2– ESR1-mutated Advanced or Metastatic Breast Cancer
26 May10m

+42 more — listen on the platforms above

Active· last episode 24 days ago

Rate this show

~15 min episodes

1
S8 Ep34: Mercado and Kovacs Emphasize the Importance of Multidisciplinary Lung Cancer Screening and Management
26 May27m
2
S8 Ep33: Kishan Discusses GI Toxicity Reduction With MRI-Guided SBRT in Prostate Cancer
26 May17m
3
S8 Ep19: FDA Approval Insights: Tucatinib and Trastuzumab in HER2+ mCRC
26 May10m
4
S8 Ep6: FDA Approval Insights: Tremelimumab Plus Durvalumab and Chemotherapy in NSCLC
26 May13m
5
S8 Ep5: Acuna Discusses US Liver Cancer Incidence in Individuals of Mexican Descent
26 May16m
6
S8 Ep36: FDA Approval Insights: Dostarlimab in dMMR Advanced Endometrial Cancer
26 May13m
7
S8 Ep35: Gynecologic Cancer Experts Review 2023 SGO Research and Treatment Updates
26 May22m
8
S8 Ep32: FDA Approval Insights: Elacestrant in ER+/HER2– ESR1-mutated Advanced or Metastatic Breast Cancer
26 May10m

+42 more — listen on the platforms above